Davids, Matthew S. http://orcid.org/0000-0003-4529-2003
Fisher, David C.
Tyekucheva, Svitlana http://orcid.org/0000-0002-3119-6507
McDonough, Mikaela
Hanna, John
Lee, Brandon
Francoeur, Karen
Montegaard, Josie
Odejide, Oreofe
Armand, Philippe
Arnason, Jon
Brown, Jennifer R.
Article History
Received: 5 May 2020
Revised: 27 July 2020
Accepted: 29 July 2020
First Online: 20 August 2020
Compliance with ethical standards
:
: M.S.D. has received grants from Acerta Pharma, BMS, Genentech, MEI Pharma, Pharmacyclics, Surface Oncology, TG Therapeutics and Verastem, and consulting fees from AbbVie, Adaptive Biotechnologies, Ascentage Pharma, AstraZeneca, BeiGene, Celgene, Genentech, Gilead Sciences, Infinity Pharmaceuticals, Janssen, Loxo, MEI Pharma, Merck, Pharmacyclics, Sunesis, Syros Pharmaceuticals, TG Therapeutics, and Verastem; D.C.F. received consulting fees from Merck, Kite, and Gilead; K.F. is an employee of Verastem; J.M. received consulting fees from Janssen, Pharmacyclics, and AstraZeneca; P.A. received consulting fees from Merck, BMS, Infinity, Pfizer, Affimed, and Adaptive, and research funding from Merck, BMS, Affimed, Adaptive, Roche, Tensha, Otsuka, and Sigma Tau; J.A. served on the scientific advisory board for Janssen, Kite Pharma, AbbVie, Karyopharm, Bayer, Gilead, Verastem, Merck, Novartis, Juno, Amgen, Celgene, Genentech, and Seattle Genetics; J.R.B. received consulting fees from AbbVie, Acerta, Astellas, AstraZeneca, BeiGene, Celgene, Genentech/Roche, Gilead, Invectys, Janssen, Kite, Loxo, Morphosys, Novartis, Pfizer, Pharmacyclics, Rectx, Sun, Sunesis, Teva, TG Therapeutics, Verastem and Novartis; grants from Gilead, Loxo, Sun and Verastem; and served on the Data Safety Monitoring Boards for Morphosys and Invectys. S.T., M.M., J.H., and O.O. have nothing to disclose.